Adriamycin combinations in advanced breast cancer:A southwest oncology group study
Open Access
- 1 March 1982
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Combined chemoimmunotherapy for advanced breast cancer.A comparison of BCG and levamisoleCancer, 1979
- Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC)Cancer, 1979
- Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycinCancer, 1979
- Adriamycin in combination for the treatment of breast cancer.A southwest oncology group studyCancer, 1978
- A randomized comparative trial of adriamycin versus methotrexate in combination drug therapyCancer, 1978
- A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer.A southeastern cancer study group projectCancer, 1977
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975